Literature DB >> 16971643

Susceptibilities of Propionibacterium acnes ophthalmic isolates to ertapenem, meropenem, and cefepime.

Robert Shames1, Farhana Satti, Ernestine M Vellozzi, Miriam A Smith.   

Abstract

We investigated the in vitro susceptibilities of 23 Propionibacterium acnes ophthalmic isolates to ertapenem, meropenem, and cefepime by utilizing the Etest. The MICs ranged from 0.094 microg/ml to 0.75 microg/ml, 0.094 microg/ml to 1.5 microg/ml, and 1 microg/ml to 12 microg/ml for ertapenem, meropenem, and cefepime, respectively. Based on our excellent in vitro carbapenem susceptibility results, in vivo studies using ertapenem and meropenem in a rabbit model of P. acnes endophthalmitis are warranted.

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16971643      PMCID： PMC1698324          DOI： 10.1128/JCM.00722-06

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  8 in total

1.  Susceptibilities of Propionibacterium acnes ophthalmic isolates to moxifloxacin.

Authors:  P Dali; E R Giugliano; E M Vellozzi; M A Smith
Journal:  Antimicrob Agents Chemother       Date:  2001-10       Impact factor: 5.191

2.  Treatment strategies for postoperative Propionibacterium acnes endophthalmitis.

Authors:  A J Aldave; J D Stein; V A Deramo; G K Shah; D H Fischer; J I Maguire
Journal:  Ophthalmology       Date:  1999-12       Impact factor: 12.079

3.  Treatment of experimental methicillin-resistant Staphylococcus epidermidis endophthalmitis with intravitreal vancomycin and intravitreal dexamethasone.

Authors:  M A Smith; J A Sorenson; G D'Aversa; S Mandelbaum; I Udell; W Harrison
Journal:  J Infect Dis       Date:  1997-02       Impact factor: 5.226

Review 4.  Diagnosis and treatment of chronic postoperative bacterial endophthalmitis.

Authors:  S E Brady; E J Cohen; D H Fischer
Journal:  Ophthalmic Surg       Date:  1988-08

5.  Treatment strategies and visual acuity outcomes in chronic postoperative Propionibacterium acnes endophthalmitis.

Authors:  W L Clark; P K Kaiser; H W Flynn; A Belfort; D Miller; D M Meisler
Journal:  Ophthalmology       Date:  1999-09       Impact factor: 12.079

6.  Susceptibility testing of Propionibacterium acnes comparing agar dilution with E test.

Authors:  M A Smith; P Alperstein; K France; E M Vellozzi; H D Isenberg
Journal:  J Clin Microbiol       Date:  1996-04       Impact factor: 5.948

7.  Evaluation of the E test for susceptibility testing of anaerobic bacteria.

Authors:  D M Citron; M I Ostovari; A Karlsson; E J Goldstein
Journal:  J Clin Microbiol       Date:  1991-10       Impact factor: 5.948

8.  Treatment of experimental methicillin-resistant Staphylococcus epidermidis endophthalmitis with intravitreal vancomycin.

Authors:  M A Smith; J A Sorenson; F D Lowy; J L Shakin; W Harrison; F A Jakobiec
Journal:  Ophthalmology       Date:  1986-10       Impact factor: 12.079
  8 in total
  2 in total

Review 1.  Propionibacterium acnes: from commensal to opportunistic biofilm-associated implant pathogen.

Authors:  Yvonne Achermann; Ellie J C Goldstein; Tom Coenye; Mark E Shirtliff
Journal:  Clin Microbiol Rev       Date:  2014-07       Impact factor: 26.132

2.  Chronic postoperative endophthalmitis: a review of clinical characteristics, microbiology, treatment strategies, and outcomes.

Authors:  Fadi Maalouf; Marwan Abdulaal; Rola N Hamam
Journal:  Int J Inflam       Date:  2012-02-22
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.